A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 84,600 shares of DGX stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84,600
Previous 120,300 29.68%
Holding current value
$11.6 Million
Previous $16.5 Million 29.57%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$137.09 - $137.09 $57.4 Million - $57.4 Million
-419,014 Reduced 35.9%
748,133 $103 Million
Q2 2024

Aug 14, 2024

BUY
$125.91 - $144.34 $128 Million - $147 Million
1,018,286 Added 684.05%
1,167,147 $160 Million
Q1 2024

May 15, 2024

SELL
$123.78 - $142.11 $6.51 Million - $7.47 Million
-52,563 Reduced 26.1%
148,861 $19.8 Million
Q4 2023

Feb 14, 2024

BUY
$120.62 - $141.12 $15.3 Million - $17.9 Million
126,775 Added 169.83%
201,424 $27.8 Million
Q3 2023

Nov 14, 2023

SELL
$121.86 - $144.92 $6.45 Million - $7.67 Million
-52,914 Reduced 41.48%
74,649 $9.1 Million
Q2 2023

Aug 14, 2023

SELL
$130.56 - $146.84 $6.26 Million - $7.04 Million
-47,950 Reduced 27.32%
127,563 $17.9 Million
Q1 2023

May 15, 2023

BUY
$131.53 - $155.76 $20.1 Million - $23.8 Million
153,093 Added 682.84%
175,513 $24.8 Million
Q4 2022

Feb 14, 2023

SELL
$123.31 - $157.26 $11 Million - $14 Million
-89,321 Reduced 79.94%
22,420 $3.51 Million
Q3 2022

Nov 14, 2022

BUY
$121.77 - $141.1 $3.76 Million - $4.36 Million
30,909 Added 38.24%
111,741 $13.7 Million
Q2 2022

Aug 15, 2022

BUY
$127.07 - $145.39 $9.88 Million - $11.3 Million
77,749 Added 2521.86%
80,832 $10.7 Million
Q1 2022

May 16, 2022

SELL
$129.09 - $164.35 $11.6 Million - $14.7 Million
-89,486 Reduced 96.67%
3,083 $422,000
Q4 2021

Feb 14, 2022

SELL
$140.36 - $173.01 $4.59 Million - $5.65 Million
-32,674 Reduced 26.09%
92,569 $16 Million
Q3 2021

Nov 15, 2021

BUY
$132.95 - $158.0 $6.22 Million - $7.39 Million
46,794 Added 59.65%
125,243 $18.2 Million
Q2 2021

Aug 16, 2021

BUY
$126.66 - $141.48 $3.43 Million - $3.83 Million
27,068 Added 52.68%
78,449 $10.4 Million
Q1 2021

May 17, 2021

SELL
$114.63 - $133.34 $18.1 Million - $21 Million
-157,544 Reduced 75.41%
51,381 $6.59 Million
Q4 2020

Feb 16, 2021

BUY
$112.7 - $128.05 $17 Million - $19.4 Million
151,259 Added 262.3%
208,925 $24.9 Million
Q3 2020

Nov 16, 2020

SELL
$107.05 - $130.01 $125 Million - $152 Million
-1,168,807 Reduced 95.3%
57,666 $6.6 Million
Q2 2020

Aug 14, 2020

BUY
$73.34 - $122.61 $88.1 Million - $147 Million
1,201,775 Added 4865.88%
1,226,473 $140 Million
Q1 2020

May 15, 2020

SELL
$75.14 - $115.68 $555,735 - $855,569
-7,396 Reduced 23.04%
24,698 $1.98 Million
Q4 2019

Feb 14, 2020

SELL
$100.29 - $107.99 $56.7 Million - $61 Million
-564,944 Reduced 94.62%
32,094 $3.43 Million
Q3 2019

Nov 14, 2019

BUY
$97.85 - $107.42 $47.2 Million - $51.8 Million
482,670 Added 422.03%
597,038 $63.9 Million
Q2 2019

Aug 14, 2019

BUY
$85.18 - $101.94 $9.01 Million - $10.8 Million
105,802 Added 1235.14%
114,368 $11.6 Million
Q1 2019

May 15, 2019

BUY
$80.68 - $89.92 $473,107 - $527,290
5,864 Added 217.02%
8,566 $0
Q4 2018

Feb 14, 2019

SELL
$79.75 - $108.38 $39.9 Million - $54.2 Million
-499,844 Reduced 99.46%
2,702 $224,000
Q3 2018

Nov 13, 2018

SELL
$105.42 - $114.99 $90.9 Million - $99.2 Million
-862,545 Reduced 63.19%
502,546 $0
Q2 2018

Aug 10, 2018

BUY
$97.35 - $113.14 $81.3 Million - $94.5 Million
835,421 Added 157.72%
1,365,091 $0
Q1 2018

May 11, 2018

BUY
$96.42 - $107.88 $26.4 Million - $29.5 Million
273,899 Added 107.09%
529,670 $53.1 Million
Q4 2017

Feb 09, 2018

SELL
$90.86 - $100.24 $5.58 Million - $6.16 Million
-61,428 Reduced 19.37%
255,771 $25.2 Million
Q3 2017

Nov 09, 2017

BUY
$91.96 - $108.35 $29.2 Million - $34.4 Million
317,199
317,199 $29.7 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.